Recurrent Small Cell Lung Cancer Life Expectancy

Learn about staging life expectancy and causes.

Recurrent small cell lung cancer life expectancy.

Non small cell lung cancer. Non small cell lung cancer which are about 80 to 85 percent of all lung cancers lung cancers most typically spread to other parts of the body through the lymph vessels and blood vessels. There are two types of lung cancer. Lung cancer is often not detected until it has spread.

The seer database however does not group cancers by ajcc tnm stages stage 1 stage 2 stage 3 etc. Life expectancy for cancers is typically expressed as a 5 year survival rate the percent of patients who will be alive 5 years after diagnosis. When deciding on the next. In small cell lung cancer extensive stage the average life expectancy is believed to be 9 to 12 months.

Approximately 15 percent of the people diagnosed with lung cancer suffer from small cell lung cancer sclc. Small cell lung cancer sclc is generally divided into two stages limited stage and extended stage. The risk of recurrence varies by the stage of cancer of which nsclc has five stage 0 through stage 4. Around three in 10 people will experience relapse with stage 1.

The other kind is. The seer database tracks 5 year relative survival rates for non small cell lung cancer nsclc and small cell lung cancer sclc in the united states based on how far the cancer has spread. Extensive stage sclc has spread far from the original tumor. And if the person does not opt for proper treatment it can go down to 4 to 6 months.

Overall the 5 year survival rate for lung cancer is lower than other cancers at 18 6. Among people with non small cell lung cancer nsclc the most common form of the disease between 30 and 55 will experience recurrence. If you or a loved one has been diagnosed with stage iv non small cell lung cancer one of the first questions that may come to mind is what is the life expectancy as the most advanced stage of the disease in which cancer has spread metastasized from the primary tumor to distant organs stage iv lung cancer has a median survival time of around four months. The progress that has been made in the treatment of small cell lung cancer has resulted from improved development of multi modality treatments and participation in clinical trials.

The other kind is small cell lung cancer sclc. Only 15 of lung cancer cases are small cell lung cancer sclc.